Loading...
XSHG
688101
Market cap751mUSD
Jul 10, Last price  
17.11CNY
1D
11.39%
1Q
4.27%
IPO
-25.77%
Name

Suntar Environmental Technology Co Ltd

Chart & Performance

D1W1MN
XSHG:688101 chart
P/E
15.04
P/S
3.74
EPS
1.14
Div Yield, %
1.50%
Shrs. gr., 5y
-0.29%
Rev. gr., 5y
11.64%
Revenues
1.52b
+9.27%
363,511,600460,604,200425,655,700474,388,700466,341,700544,464,674585,941,725589,908,834742,008,730876,447,1011,150,709,0661,259,160,6851,450,529,2001,390,872,6681,519,753,400
Net income
378m
+19.95%
101,496,700113,614,70089,400,40082,768,200107,198,700128,716,703185,231,022181,321,749276,645,834221,805,920247,121,750217,881,935253,940,591314,813,998377,616,500
CFO
338m
+96.85%
129,555,40040,598,90040,755,60069,368,40057,018,000194,683,815124,583,488100,565,887236,317,186118,098,323221,133,458247,329,288244,615,864171,905,993338,395,461
Dividend
Jul 05, 20240.23 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Suntar Environmental Technology Co., Ltd., established in 2005 and headquartered in Xiamen, China, specializes in delivering advanced industrial membrane separation solutions across the nation. The company's extensive service portfolio includes ceramic, spiral, and PP/PE membrane separation techniques, alongside sophisticated offerings such as flow-cel membrane technology, solvent recovery systems, membrane bioreactor (MBR) applications, continuous chromatography separation, and ion exchange processes. Additionally, Suntar manufactures and supplies a variety of specialized products, including ceramic, spiral wound, hollow fiber, and spiral membranes, as well as laboratory equipment and Integrated Membrane Bioreactors (IMBRs). Their tailored solutions cater to a diverse clientele within the biological, chemical engineering, pharmaceutical, and food and beverage sectors.
IPO date
Nov 15, 2019
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT